A First-in-Human Study of the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ- 88549968, a T-cell Redirecting Bispecific Antibody for CALR mutated Myeloproliferative Neoplasms

Principal Investigator

Dr Bethan Psaila

Contact us

Email: orh-tr.earlyphasenurses@nhs.net

IRAS number

1008190